ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1948 participants.
Also called NCT03735667
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,948 participants
- Sponsor
- Registry
-
NCT03735667
-
- Main results
- ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03735667. Randomized; no masking; primary purpose treatment. Start 2019-06-10 (actual); primary completion 2024-06-14 (actual). Results posted on 2025-04-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
- Condition
- Aortic Stenosis
- Intervention (Device)
- ACURATE neo2™ Transfemoral TAVR System
- Intervention (Device)
- Medtronic CoreValve TAVR System
- Intervention (Device)
- Edwards SAPIEN 3 TAVR System
- Intervention (Device)
- ACURATE Prime™ Transfemoral TAVR System XL
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct03735667- Content hash
62c5ee19be10b0126ef4a59561e4b55fbbd06af969df3ab264dfe82a1b482080